Literature DB >> 31555555

Lower urinary tract symptoms (LUTS) before and after robotic-assisted laparoscopic prostatectomy: does improvement of LUTS mitigate worsened incontinence after robotic prostatectomy?

Lukas Dommer1, Jan A Birzele1, Khosrow Ahmadi1, Mario Rampa1, Daniel J Stekhoven2, Räto T Strebel1.   

Abstract

BACKGROUND: Urinary incontinence is a major concern for patients scheduled for radical prostatectomy. However, after prostatectomy lower urinary tract symptoms (LUTS) may improve and thus mitigate this concern. We assessed LUTS and its interference with the quality of life (QoL) using the short form of the international continence society male questionnaire (ICSMALESF-Q) in patients before and after robot-assisted radical prostatectomy (RARP). Furthermore, we aimed to identify risk factors for postoperative urinary incontinence.
METHODS: Data of all patients who underwent RARP from 2009 to 2014 were prospectively collected in our customized database. We identified 453 eligible patients for whom a preoperative and at least two postoperative datasets including ICSMALESF-Q were available.
RESULTS: Both the ICSMALESF-Q at 6 months (P<0.001) and the related QoL at 12 months (P<0.01) have significantly improved after RARP (P<0.001). Two years after RARP ICSMALESF-Q and thus LUTS have improved in 64%, remained unchanged in 18% and worsened in 18% of patients. The daily pad use was 0 in 79% and 0 or 1 pad in 95.6%, respectively. Increased patient age (P<0.05) was significantly associated with an increased average number of pads used per day (multiplicative effect: +2.1% pads for each year). Being in the D'Amico low-risk group reduced the average number of pads used by 22% (P<0.05, multiplicative effect 0.780). The prostate volume, planned nerve sparing, adjuvant or salvage radiotherapy, body mass index (BMI), or a history of transurethral resection of the prostate (TUR-P) before radical prostatectomy were not associated with the postoperative pad use or changes in LUTS.
CONCLUSIONS: The ICSMALESF-Q and thus LUTS have significantly improved in a majority of patients after RARP and hence the associated QoL improved as well. Preoperative D'Amico low-risk group significantly reduced pad use after RARP, whereas increased age significantly increased postoperative pad use. These results will help providers counsel their patients more appropriately before prostatectomy by focusing not only on pad use and incontinence after RARP, but also on changes of the bothersomeness of LUTS and risk factors in general.

Entities:  

Keywords:  Lower urinary tract symptoms (LUTS); patient reported outcome measures prostatectomy; urinary incontinence

Year:  2019        PMID: 31555555      PMCID: PMC6732103          DOI: 10.21037/tau.2019.06.24

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


  28 in total

1.  Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms.

Authors:  E J Schwartz; H Lepor
Journal:  J Urol       Date:  1999-04       Impact factor: 7.450

2.  The learning curve of robot-assisted radical prostatectomy.

Authors:  Eyup Gumus; Ugur Boylu; Turgay Turan; Fikret Fatih Onol
Journal:  J Endourol       Date:  2011-08-04       Impact factor: 2.942

3.  Functional and oncologic outcomes comparing interfascial and intrafascial nerve sparing in robot-assisted laparoscopic radical prostatectomies.

Authors:  Lindsay Potdevin; Matt Ercolani; Jeongyun Jeong; Isaac Yi Kim
Journal:  J Endourol       Date:  2009-09       Impact factor: 2.942

4.  Periurethral suspension stitch during robot-assisted laparoscopic radical prostatectomy: description of the technique and continence outcomes.

Authors:  Vipul R Patel; Rafael F Coelho; Kenneth J Palmer; Bernardo Rocco
Journal:  Eur Urol       Date:  2009-06-16       Impact factor: 20.096

Review 5.  Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy.

Authors:  Vincenzo Ficarra; Giacomo Novara; Raymond C Rosen; Walter Artibani; Peter R Carroll; Anthony Costello; Mani Menon; Francesco Montorsi; Vipul R Patel; Jens-Uwe Stolzenburg; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Alexandre Mottrie
Journal:  Eur Urol       Date:  2012-06-01       Impact factor: 20.096

6.  Surgery for high-risk localized prostate cancer.

Authors:  Jan Schmitges; Quoc-Dien Trinh; Jochen Walz; Markus Graefen
Journal:  Ther Adv Urol       Date:  2011-08

7.  Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.

Authors:  Andreas Ihrig; Monika Keller; Mechthild Hartmann; Jürgen Debus; Jesco Pfitzenmaier; Boris Hadaschik; Markus Hohenfellner; Wolfgang Herzog; Johannes Huber
Journal:  BJU Int       Date:  2011-03-16       Impact factor: 5.588

8.  Scoring the short form ICSmaleSF questionnaire. International Continence Society.

Authors:  J L Donovan; T J Peters; P Abrams; S T Brookes; J J de aa Rosette; W Schäfer
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

9.  Independent predictors of recovery of continence 3 months after robot-assisted laparoscopic radical prostatectomy.

Authors:  Jung Jun Kim; Yun-Sok Ha; Jeong Hyun Kim; Seong Soo Jeon; Dong-Hyeon Lee; Wun-Jae Kim; Isaac Yi Kim
Journal:  J Endourol       Date:  2012-09-24       Impact factor: 2.942

10.  Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.

Authors:  Joshua D Hall; James C Boyd; Marguerite C Lippert; Dan Theodorescu
Journal:  Urology       Date:  2003-02       Impact factor: 2.649

View more
  1 in total

1.  Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.

Authors:  Salome Adam; Eva Martin-Diener; Bertrand Camey; Céline Egger Hayoz; Isabelle Konzelmann; Seyed Mohsen Mousavi; Christian Herrmann; Sabine Rohrmann; Miriam Wanner; Katharina Staehelin; Räto T Strebel; Marco Randazzo; Hubert John; Hans-Peter Schmid; Volker Arndt
Journal:  Cancer Med       Date:  2020-06-10       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.